Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 3.61B | 2.67B |
| Cost of revenue | 609M | 462M |
| Research and development | 648M | 552M |
| Selling, general and administrative | 704M | 600M |
| Interest expense | 1.16B | 1.09B |
| Pre-tax income | 526M | 233M |
| Income tax | 45M | −265M |
| Net income | 481M | 499M |
| Earnings per share | 0.42 | 0.46 |
| Earnings per share, diluted | 0.39 | 0.39 |
| Weighted average shares | 1.15B | 1.05B |
| Weighted average shares, diluted | 1.25B | 1.10B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.40B | 4.93B | 3.25B | 2.12B | 2.09B | 2.54B | 2.35B | 2.33B |
| Goodwill | 1.39B | 1.39B | 1.39B |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −3.74B | −1.12B |
| Depreciation and amortisation | 234M | 203M |
| Share-based compensation | 262M | 246M |
| Capital expenditure | 242M | 154M |
| Investing cash flow | −6.72B | −4.82B |
| Financing cash flow | 13.11B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 1.39B |
| 1.39B |
| 1.39B |
| 1.39B |
| 1.39B |
| Total assets | 53.70B | 50.66B | 45.29B | 41.11B | 37.75B | 36.25B | 34.38B | 32.64B |
| Total liabilities | 42.89B | 40.17B | 36.51B | 34.25B | 31.07B | 29.73B | 28.26B | 26.74B |
| Equity | 10.81B | 10.49B | 8.78B | 6.86B | 6.68B | 6.53B | 6.12B | 5.90B |
| Shares outstanding | 1.28B | 1.27B | 1.20B | 1.11B | 1.10B | 1.10B | 1.08B | 1.07B |
| Shares issued | 1.28B | 1.27B | 1.20B | 1.11B | 1.10B | 1.10B | 1.08B | 1.07B |
| 5.03B |